Singapore’s oncology service provider TalkMed Group said on Monday it had received a privatisation offer from TW Troy, valuing the company at S$606.1 million ($447.24 million).
TW Troy, indirectly owned by oncology-focused group Tamarind Health, is offering TalkMed shareholders S$0.456 per share, representing a premium of nearly 5% to the stock’s last close on Friday.
The combined entity may consider a future listing on the Singapore Exchange, TalkMed Group said.
The deal also includes an investment by Temasek-backed 65 Equity Partners, resulting in an 18.3% stake in Tamarind Health.
($1 = 1.3552 Singapore dollars)
Reuters